- PCR devices are crucial tools used in molecular biology for amplifying DNA and RNA sequences, playing a pivotal role in diagnostics, research, and genetic analysis. They are widely used for detecting infectious diseases, genetic disorders, and in research applications
- The demand for PCR devices is significantly driven by the rising prevalence of infectious diseases, genetic disorders, and the growing need for early and accurate diagnostics. Advancements in PCR technology, such as real-time PCR and digital PCR, are also contributing to the increased adoption of PCR devices across healthcare settings
- North America is expected to dominate the PCR devices market with largest market share of 36.4%, due to its well-established healthcare infrastructure, high healthcare spending, and early adoption of advanced diagnostic technologies. The U.S., in particular, holds a significant share due to its strong focus on research and development in the biotechnology and diagnostics sectors
- Asia-Pacific is expected to be the fastest growing region in the polymerase chain reaction (PCR) devices market during the forecast period due to increasing investments in healthcare infrastructure, rising healthcare awareness, and improving access to advanced diagnostic tools in countries like China, India, and Japan
- Medical segment is expected to dominate the market with a largest market share of 97% due to the high adoption rate of PCR tests for clinical diagnostics and research activities to study diseases and drug development. Moreover, the growing application of PCR in the detection of SARS-CoV-2 infections and drug development and research activities is increasing the demand for tests
